BTX

BTX Overview

  • Founded
  • 1983
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

BTX General Information

Description

Provider of novel electroporation and electrofusion tools designed for the advancement of cell transfection and cell fusion. The company specializes in providing transfection solutions for cell and tissue type including eukaryotes, prokaryotes, in vivo tissues, in ovo, in utero, adherent and suspension cultures, plant cells, dermal and muscular immunizations, high throughput and cell fusion electroporation equipment to research laboratory markets.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Diagnostic Equipment
Other Industries
Other Devices and Supplies
Parent Company
Primary Office
  • 84 October Hill Raod
  • Holliston, MA 01746
  • United States
+1 (508) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

BTX Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore BTX‘s full profile, request access.

Request a free trial

BTX Executive Team (1)

Name Title Board Seat Contact Info
Bryan Bjorndal General Manager

BTX Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore BTX‘s full profile, request access.

Request a free trial